<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Muscle relaxants: anaesthesia: non-depolarising; Non-depolarising muscle relaxants see Muscle relaxants; Atracurium; Cisatracurium; Mivacurium; Pancuronium; Rocuronium; Vecuronium" /><meta name="IX" content="Muscle relaxants: anaesthesia: non-depolarising; Atracurium; Cisatracurium; Mivacurium; Pancuronium; Rocuronium; Vecuronium" /><meta name="IXN" content="Non-depolarising muscle relaxants see Muscle relaxants" /><title>Non-depolarising neuromuscular blocking drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="6647.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="6647.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=6647.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2082.htm">15 Anaesthesia</a> &gt; <a href="6559.htm">15.1 General anaesthesia</a> &gt; <a href="6646.htm">15.1.5 Neuromuscular blocking drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6646.htm" title="Previous: 15.1.5 Neuromuscular blocking drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="6650.htm" title="Next: ATRACURIUM BESILATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_6647">Non-depolarising neuromuscular blocking drugs</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i620.htm" title="Go to appendix 1">Muscle Relaxants, non-depolarising</a>).</div><div><p>Non-depolarising neuromuscular blocking drugs (also known as competitive
muscle relaxants) compete with acetylcholine for receptor sites at
the neuromuscular junction and their action can be reversed with anticholinesterases
such as <span>neostigmine</span> (<a title="BNF:monograph: NEOSTIGMINE METILSULFATE" href="6669.htm#_6669">section 15.1.6</a>). Non-depolarising neuromuscular
blocking drugs can be divided into the <b>aminosteroid</b> group, comprising pancuronium, rocuronium, and vecuronium, and the <b>benzylisoquinolinium</b> group, comprising atracurium, <span>cisatracurium</span>, and <span>mivacurium</span>.</p><p>Non-depolarising neuromuscular blocking drugs have a slower
onset of action than suxamethonium. These drugs can be classified
by their duration of action as short-acting (15–30 minutes), intermediate-acting
(30–40 minutes), and long-acting (60–120 minutes), although duration
of action is dose-dependent. Drugs with a shorter or intermediate
duration of action, such as atracurium and vecuronium, are more widely
used than those with a longer duration of action, such as pancuronium.</p><p>Non-depolarising neuromuscular blocking drugs have no sedative
or analgesic effects and are not considered to trigger malignant hyperthermia.</p><p>For patients receiving intensive care and who require tracheal
intubation and mechanical ventilation, a non-depolarising neuromuscular
blocking drug is chosen according to its onset of effect, duration
of action, and side-effects. Rocuronium, with a rapid onset of effect,
may facilitate intubation. Atracurium or <span>cisatracurium</span> may be suitable for long-term neuromuscular blockade since their
duration of action is not dependent on elimination by the liver or
the kidneys.</p><div class="cAZ" id="_6647.1"><h2>Cautions</h2> <p class="cAX">Allergic cross-reactivity between neuromuscular blocking drugs has
been reported; caution is advised in cases of hypersensitivity to
these drugs. Their activity is prolonged in patients
with myasthenia gravis and in hypothermia, and lower
doses are required. Non-depolarising neuromuscular blocking drugs
should be used with great care in those with other neuromuscular disorders
and those with fluid and electrolyte disturbances, as response is
unpredictable. Resistance can develop in patients with
burns, who may require increased doses; low plasma cholinesterase
activity in these patients requires dose titration for <span>mivacurium</span>. The rate of administration of neuromuscular blocking
drugs should be reduced in patients with cardiovascular disease. <b>Interactions:</b> Appendix 1 (muscle
relaxants).</p><div id="_6647.3"></div></div><div id="_213819"><div class="cAZ"><h2>Pregnancy</h2> <p class="cAX">Non-depolarising neuromuscular blocking
drugs are highly ionised at physiological pH and are therefore unlikely
to cross the placenta in significant amounts.</p></div></div><div id="_213820"><div class="cAZ"><h2>Breast-feeding</h2> <p class="cAX">Because they are ionised at physiological
pH, non-depolarising neuromuscular blocking drugs are unlikely to
be present in milk in significant amounts. Breast-feeding may be resumed
once the mother has recovered from neuromuscular block.</p></div></div><div id="_204201"><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Benzylisoquinolinium non-depolarising
neuromuscular blocking drugs (except <span>cisatracurium</span>) are associated with histamine release, which can cause skin flushing,
hypotension, tachycardia, bronchospasm, and very rarely anaphylactoid
reactions. Most aminosteroid neuromuscular blocking drugs produce
minimal histamine release. Drugs with vagolytic activity can counteract
any bradycardia that occurs during surgery. Acute myopathy has also
been reported after prolonged use in intensive care.</p></div></div><p><span id="_6647.2"><b>Atracurium</b>, a mixture of 10 isomers, is a benzylisoquinolinium
neuromuscular blocking drug with an intermediate duration of action.
It undergoes non-enzymatic metabolism which is independent of liver
and kidney function, thus allowing its use in patients with hepatic
or renal impairment. Cardiovascular effects are associated with significant
histamine release.</span></p><p><b><span>Cisatracurium</span></b> is a single isomer of atracurium.
It is more potent and has a slightly longer duration of action than
atracurium and provides greater cardiovascular stability because <span>cisatracurium</span> lacks histamine-releasing effects.</p><p><b><span>Mivacurium</span></b>, a benzylisoquinolinium neuromuscular
blocking drug, has a short duration of action. It is metabolised by
plasma cholinesterase and muscle paralysis is prolonged in individuals
deficient in this enzyme. It is not associated with vagolytic activity
or ganglionic blockade although histamine release can occur, particularly
with rapid injection.</p><p><b>Pancuronium</b>, an aminosteroid neuromuscular blocking drug, has a long duration
of action and is often used in patients receiving long-term mechanical
ventilation in intensive care units. It lacks a histamine-releasing
effect, but vagolytic and sympathomimetic effects can cause tachycardia
and hypertension.</p><p><b>Rocuronium</b> exerts an effect within 2 minutes and has the most rapid onset of
any of the non-depolarising neuromuscular blocking drugs. It is an
aminosteroid neuromuscular blocking drug with an intermediate duration
of action. It is reported to have minimal cardiovascular effects;
high doses produce mild vagolytic activity.</p><p><b>Vecuronium</b>, an aminosteroid neuromuscular blocking drug, has an intermediate
duration of action. It does not generally produce histamine release
and lacks cardiovascular effects.</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_6650"><a href="6650.htm" title="ATRACURIUM BESILATE">ATRACURIUM BESILATE</a></li><li id="_38919"><a href="38919.htm" title="CISATRACURIUM">CISATRACURIUM</a></li><li id="_6654"><a href="6654.htm" title="MIVACURIUM">MIVACURIUM</a></li><li id="_6656"><a href="6656.htm" title="PANCURONIUM BROMIDE">PANCURONIUM BROMIDE</a></li><li id="_18840"><a href="18840.htm" title="ROCURONIUM BROMIDE">ROCURONIUM BROMIDE</a></li><li id="_6660"><a href="6660.htm" title="VECURONIUM BROMIDE">VECURONIUM BROMIDE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6646.htm">Previous: 15.1.5 Neuromuscular blocking drugs</a> | <a class="top" href="6647.htm#">Top</a> | <a accesskey="]" href="6650.htm">Next: ATRACURIUM BESILATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>